Your browser doesn't support javascript.
The anti-C5a antibody vilobelimab efficiently inhibits C5a in severe COVID-19 patients
Molecular Immunology ; 141:222-223, 2022.
Article in English | Web of Science | ID: covidwho-1801749
Search on Google
Collection: Databases of international organizations Database: Web of Science Language: English Journal: Molecular Immunology Year: 2022 Document Type: Article

Similar

MEDLINE

...
LILACS

LIS

Search on Google
Collection: Databases of international organizations Database: Web of Science Language: English Journal: Molecular Immunology Year: 2022 Document Type: Article